TrialCancer prevention research (Philadelphia, Pa.)2018

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.

Ayca Gucalp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.